BLFS
Price
$21.48
Change
+$0.11 (+0.51%)
Updated
Jun 26 closing price
Capitalization
810.87M
41 days until earnings call
XGN
Price
$6.97
Change
+$0.20 (+2.95%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
27.06M
45 days until earnings call
Interact to see
Advertisement

BLFS vs XGN

Header iconBLFS vs XGN Comparison
Open Charts BLFS vs XGNBanner chart's image
BioLife Solutions
Price$21.48
Change+$0.11 (+0.51%)
Volume$688.34K
Capitalization810.87M
Exagen
Price$6.97
Change+$0.20 (+2.95%)
Volume$12.32K
Capitalization27.06M
BLFS vs XGN Comparison Chart in %
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. XGN commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Buy and XGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (BLFS: $21.48 vs. XGN: $6.99)
Brand notoriety: BLFS and XGN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 123% vs. XGN: 52%
Market capitalization -- BLFS: $810.87M vs. XGN: $27.06M
BLFS [@Medical Specialties] is valued at $810.87M. XGN’s [@Medical Specialties] market capitalization is $27.06M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileXGN’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • XGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both BLFS and XGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 2 TA indicator(s) are bullish while XGN’s TA Score has 4 bullish TA indicator(s).

  • BLFS’s TA Score: 2 bullish, 7 bearish.
  • XGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, XGN is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Medical Specialties) experienced а -0.19% price change this week, while XGN (@Medical Specialties) price change was -5.03% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.93%. For the same industry, the average monthly price growth was +0.51%, and the average quarterly price growth was +0.02%.

Reported Earning Dates

BLFS is expected to report earnings on Aug 07, 2025.

XGN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Medical Specialties (+0.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($811M) has a higher market cap than XGN($27.1M). XGN YTD gains are higher at: 70.488 vs. BLFS (-17.257). XGN has higher annual earnings (EBITDA): -19.15M vs. BLFS (-45.24M). BLFS has more cash in the bank: 51.7M vs. XGN (36.5M). XGN has less debt than BLFS: XGN (23.7M) vs BLFS (42.7M). BLFS has higher revenues than XGN: BLFS (143M) vs XGN (52.5M).
BLFSXGNBLFS / XGN
Capitalization811M27.1M2,993%
EBITDA-45.24M-19.15M236%
Gain YTD-17.25770.488-24%
P/E Ratio238.10N/A-
Revenue143M52.5M272%
Total Cash51.7M36.5M142%
Total Debt42.7M23.7M180%
FUNDAMENTALS RATINGS
BLFS: Fundamental Ratings
BLFS
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
14
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLFSXGN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRCOX60.50N/A
N/A
T. Rowe Price U.S. Equity Research
FSCVX24.94N/A
N/A
Nuveen Small Cap Value C
CGOAX25.82N/A
N/A
Columbia Small Cap Growth A
VMMSX24.32N/A
N/A
Vanguard Emerg Mkts Sel Stk Inv
MADFX34.41N/A
N/A
Matrix Advisors Dividend

XGN and

Correlation & Price change

A.I.dvisor tells us that XGN and MXCT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XGN and MXCT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XGN
1D Price
Change %
XGN100%
+3.25%
MXCT - XGN
29%
Poorly correlated
+3.14%
BLFS - XGN
26%
Poorly correlated
+0.51%
RDNT - XGN
26%
Poorly correlated
+3.48%
NOTV - XGN
26%
Poorly correlated
+1.66%
QDEL - XGN
26%
Poorly correlated
+2.10%
More